Showing results (111-120 of 186) with videos related to

Sort By:
Pageof 19
Blood Advances|May 5, 2026
Polatuzumab vedotin-containing regimens as bridge to CART: analysis from the CART-SIE studyGiulia Gabrielli, Beatrice Casadei, Annalisa Chiappella, et al.
Leukemia & Lymphoma|January 11, 2025
Interim-PET predicts progression-free survival in stage IV Hodgkin lymphoma treated with upfront brentuximab vedotin-AVDChiara Rusconi, Angelica Barone, Andrea Visentin, et al.
British Journal of Haematology|March 9, 2026
Renal dysfunction in symptomatic Waldenström macroglobulinaemia: A nationwide Italian multicentre studyNicolò Danesin, Francesco Autore, Anna Maria Frustaci, et al.
Blood|January 27, 2011
The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformationDavide Rossi, Valeria Spina, Clara Deambrogi, et al.
The American Journal of Surgical Pathology|January 26, 2011
Molecular characteristics of mantle cell lymphoma presenting with clonal plasma cell componentCarlo Visco, Sylvia Hoeller, Jeffrey T Malik, et al.
The American Journal of Pathology|June 20, 2017
AKT Hyperactivation and the Potential of AKT-Targeted Therapy in Diffuse Large B-Cell LymphomaJinfen Wang, Zijun Y Xu-Monette, Kausar J Jabbar, et al.
Blood Advances|May 12, 2023
Long-term follow-up of rituximab plus bendamustine and cytarabine in older patients with newly diagnosed MCLMaria Chiara Tisi, Riccardo Moia, Caterina Patti, et al.
Pageof 19